Keros Therapeutics (KROS) has shared an announcement.
Keros Therapeutics, Inc. has refreshed its corporate presentation and made it accessible to investors and analysts via its website. This move, aimed at keeping the investment community informed, is part of the company’s ongoing communication strategy but does not constitute an official filing for regulatory purposes. The presentation’s content remains informal, and while it is attached to a current report, it is not considered legally binding or a part of the company’s formal disclosures.
For an in-depth examination of KROS stock, go to TipRanks’ Stock Analysis page.
